1. I-Mab to Initiate the Development of TJM2 for Treating Cytokine Release Syndrome Associated with COVID-19 Published: Mar 13, 2020 | Tags: I-Mab, Initiate, Development, TJM2, Treating, Cytokine Release Syndrome, COVID-19 […]readmore
Tags : ¬Bora Pharmaceuticals
Shots: Bora acquires GSK’s facility located in Mississauga, Ontario (Canada) which produces ~50 products and employs ~400 skilled manufacturing staff. The transaction is expected to be completed in H2’20 As […]readmore